Transforming growth factor-β1 (TGF-β1) signaling is suppressed by NOTCH2, and this signaling is linked to the upkeep of chronic inflammation, such as NAFLD [12]. This evidence concerns the gene NOTCH2 and metabolic dysfunction-associated steatotic liver disease.